Margaret Horn | Chief Operating Officer |
Mark Goldsmith | Chairman & Chief Executive Officer |
Jack Anders | Senior Vice President of Finance & Principal Accounting Officer |
Steve Kelsey | President of R&D |
Alec Stranahan | Bank of America |
Faisal Khurshid | SVB Securities |
Eric Joseph | JPMorgan |
Marc Frahm | Cowen |
Michael Schmidt | Guggenheim Partners |
Chris Shibutani | Goldman Sachs |
Jay Olson | Oppenheimer |
Good day and thank you for standing by. Welcome to the Revolution Medicines Third Quarter 2022 Earnings Webcast. [Operator Instructions] I would now like to hand the conference over to Peg Horn, Revolution Medicine's Chief Operating Officer for opening remarks. Peg, you may begin.
Thank you and welcome, everyone, to our third-quarter earnings call.